Lobbying Information
Subject Matters
- Aboriginal Affairs
- Health
- Industry
- Intellectual Property
- Internal Trade
- International Relations
- International Trade
- Justice and Law Enforcement
- Regional Development
- Research and Development
- Science and Technology
Subject Matter Details
Legislative Proposal, Bill or Resolution
- Patent Act as it relates to the regulation of intellectual property for therapeutic products
Legislative Proposal, Bill or Resolution, Policies or Program
- Comprehensive Economic and Trade Agreement Negotiations as it relates to the protection of intellectual property rights.
Legislative Proposal, Bill or Resolution, Regulation
- Food and Drugs Act Regulations, specifically with respect to approval, regulation and life-cycle management of therapeutic products
Policies or Program
- Federal public drug plans, specifically the Non-Insured Health Benefits Program (Health Canada), with respect to decisions and policies that impact reimbursement of therapeutic products for plan beneficiaries
- Policy or program: National pharmacare with respect to the coordinaton of drug plan policies and programs
- Research and Development Legislative Proposal, Policy or Program, with respect to the strategy on innovation.
- Science and Technology Strategy led by Industry Canada, particularly with respect to the life sciences priority under the S&T Strategy
Policies or Program, Regulation
- Patented Medicines Prices Review Board with respect to amendments to the guidelines for the regulation of pricing of patented drug products patentees
- Patented Medicines Prices Review Board with respect to decisions on the reporting obligations of patented drug products patentees
Regulation
- Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations.
Communication Techniques
-
Written communication
-
Oral communication
-
Grass-roots communication
-
Meetings, presentations and telephone communication
Government Institutions
-
Aboriginal Affairs and Northern Development Canada
-
Employment and Social Development Canada (ESDC)
-
Federal Office of Regional Development – Quebec (FORD[Q])
-
Finance Canada (FIN)
-
Foreign Affairs, Trade and Development Canada
-
Health Canada (HC)
-
House of Commons
-
Industry Canada
-
Infrastructure Canada (INFC)
-
Justice Canada (JC)
-
Members of the House of Commons
-
National Defence (DND)
-
National Research Council (NRC)
-
Natural Resources Canada (NRCan)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Privy Council Office (PCO)
-
Public Works and Government Services Canada
-
Senate of Canada
-
Treasury Board Of Canada Secretariat (TBS)
-
Veterans Affairs Canada (VAC)
-
Western Economic Diversification Canada (WD)
Government institutions added through a monthly communication report
- Global Affairs Canada (GAC)
- Innovation, Science and Economic Development Canada (ISED)
In-house Corporation Details
Description of activities
Innovative pharmaceutical company - marketing and sales of drugs, medical devices, natural health products, cosmetics and offer of therapeutic solutions.
Responsible officer name and position during the period of this registration
Niven Al-Khoury,
President and Chief Executive Officer (CEO)
Government funding
No government funding was received during the last completed financial year.
In-house Corporation Contact Information
Address:
2905 Place Louis-R. Renaud
Laval, QC H7V 0A3
Canada
Telephone number:
514-956-6246
Fax number:
514-339-5149
Parent Company Information
- Sanofi
-
54 rue de la Boétie
Paris 75008
France
Subsidiary Beneficiary Information
- Sanofi Consumer Health Inc. / Sanofi Santé Grand Public Inc.
-
2905 Place Louis-R. Renaud
Laval, QC H7V 0A3
Canada
- sanofi-Pasteur Ltd.
-
1755 Steeles Avenue
Toronto, ON M2R 3T4
Canada
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Niven Al-Khoury,
President & CEO |
No public offices held
- Richard Grégoire,
Vice-president, Evidence, Value and Access |
No public offices held
- Franca Mancino,
Vice-president, Medical and Regulatory Affairs |
No public offices held
- Robert Quesnel,
Vice-president, Legal and Corporate Affairs |
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
- Michel G. Tremblay,
Director, Federal Affairs |
No public offices held
